Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
79.2
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (16)
○ MHRA GMP
Quick Facts: Curia (RNA/Advanced)
- Signal Score
- 79.2/100 (as of 2026-04-29)
- Quality Compliance
- 99.4/100
- Headquarters
- Albany, NY · Albuquerque, NM
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Curia (RNA/Advanced)
Formerly AMRI. Expanding into RNA therapeutics CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.4
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-12-02)
EMA GMP Certificates16 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
2 manufacturing sites
Sites: Albany, NY, Albuquerque, NM
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites
Curia (RNA/Advanced) FDA Inspection History
2025-12
2025-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-12-02 | Springfield, Missouri | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-05-09 | Albany, New York | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Jul 04, 2026
Curia (RNA/Advanced) EMA GMP Compliance 16 certificates
2026-02
2026-02
2026-01
2025-11
2025-04
2025-03
2024-12
2024-06
2023-05
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
2023-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 411/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| 10350-004/26 | Curia Spain S.A.U. | Spain | 2026-02-13 | COMPLIANT |
| IT-API/41/H/2026 | Curia Italy S.r.l. | Italy | 2026-01-16 | COMPLIANT |
| 25MPP072HFR01 | Curia France S.A.S. | France | 2025-11-27 | COMPLIANT |
| IT-API/120/H/2025 | Curia Italy S.r.l. | Italy | 2025-04-11 | COMPLIANT |
| 25MPP015HFR01 | Curia France S.A.S. | France | 2025-03-28 | COMPLIANT |
| IT-API/29/H/2025 | Curia Italy S.r.l. | Italy | 2024-12-05 | COMPLIANT |
| 24MPP026HFR01 | Curia France S.A.S. | France | 2024-06-07 | COMPLIANT |
| IT-API/20/H/2024 | Curia Italy S.r.l. | Italy | 2023-05-25 | COMPLIANT |
| M00611-03/23/02 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-02/23/01 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| 10350-004/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-01/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-03/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| M00611-02/23 | Curia Spain S.A.U. | Spain | 2023-02-27 | COMPLIANT |
| IT-API/265/H/2023 | Curia Italy S.r.l. | Italy | 2023-02-24 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Frequently Asked Questions About Curia (RNA/Advanced)
How many FDA inspections does Curia (RNA/Advanced) have on record?
CDMO Signal tracks 2 FDA inspections for Curia (RNA/Advanced), sourced from the FDA inspection database. See the full inspection history above.
Has Curia (RNA/Advanced) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Curia (RNA/Advanced).
Does Curia (RNA/Advanced) hold EMA or MHRA GMP certificates?
CDMO Signal tracks 16 EMA GMP certificates for Curia (RNA/Advanced).
What is Curia (RNA/Advanced)'s CDMO Signal Score?
Curia (RNA/Advanced) has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating Curia (RNA/Advanced) for a manufacturing program?
Use the free AI matchmaker to compare Curia (RNA/Advanced) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy